Table 2.
Incidence rates, rate differences (RD), and rate ratios (RR) of infant outcomes associated with receipt of Tdap during pregnancy at 7 Vaccine Safety Datalink sites, 2010–2013, (N = 197,564), by time period during pregnancy in which Tdap was administered and limiting results to infants born < 34 weeks gestation.
Maternal Tdap administration during pregnancy at any time during pregnancy, 2010–2013 |
Adjusted measures of association 95% CI | |||||
---|---|---|---|---|---|---|
No (n = 152,556) |
Yes (n = 45,008) |
|||||
n | Incidence rate % | n | Incidence rate % | RD in cases per 100 live births | RR | |
Chorioamnionitis | 7970 | 5.22 | 2883 | 6.41 | 1.16 (0.9, 1.42) | 1.23 (1.17, 1.28) |
Composite outcome | 4824 | 3.16 | 1288 | 2.86 | 0.11 (−0.07, 0.29) | 1.04 (0.98, 1.11) |
TTNa | 3524 | 2.31 | 973 | 2.16 | 0.07 (−0.09, 0.22) | 1.03 (0.96, 1.11) |
Neonatal sepsisb | 939 | 0.62 | 231 | 0.51 | 0.03 (−0.05, 0.10) | 1.06 (0.91, 1.23) |
Pneumoniac | 371 | 0.24 | 73 | 0.16 | 0.00 (−0.04, 0.04) | 0.94 (0.72, 1.22) |
RDSd | 215 | 0.14 | 49 | 0.11 | −0.01 (−0.05, 0.03) | 0.91 (0.66, 1.26) |
Convulsions in newborne | 261 | 0.17 | 68 | 0.15 | 0.02 (−0.02, 0.06) | 1.16 (0.87, 1.53) |
Maternal Tdap administration during recommended time period of pregnancy, 27–36 weeks, 2010–2013 |
||||||
No (n = 133,882) |
Yes (n = 22,772) |
|||||
n | Incidence rate % | n | Incidence rate % | RD in cases per 100 live births | RR | |
Chorioamnionitis | 7109 | 5.31 | 1430 | 6.28 | 0.98 (0.65,1.32) | 1.20 (1.14, 1.28) |
Composite outcome | 4157 | 3.10 | 653 | 2.87 | 0.13 (−0.11, 0.37) | 1.02 (0.94, 1.12) |
TTN | 3061 | 2.29 | 520 | 2.28 | 0.20 (−0.02, 0.41) | 1.08 (0.98, 1.19) |
Neonatal sepsis | 785 | 0.59 | 101 | 0.44 | −0.01 (−0.11, 0.08) | 0.90 (0.73, 1.11) |
Pneumonia | 329 | 0.25 | 34 | 0.15 | −0.01 (−0.06, 0.05) | 0.82 (0.57, 1.17) |
RDS | 168 | 0.13 | 21 | 0.09 | −0.02 (−0.06, 0.03) | 0.79 (0.50, 1.26) |
Convulsions in newborn | 229 | 0.17 | 28 | 0.12 | −0.01 (−0.06, 0.04) | 0.88 (0.58, 1.31) |
Maternal Tdap administration at any time during pregnancy, infants born < 34 weeks GA |
||||||
No (n = 2711) |
Yes (n = 426) |
|||||
n | Incidence rate % | n | Incidence rate % | RD in cases per 100 live births | RR | |
Chorioamnionitis | 221 | 8.15 | 28 | 6.57 | −1.02 (−3.51, 1.47) | 0.87 (0.59, 1.30) |
Composite outcome | 695 | 25.64 | 104 | 24.41 | 0.18 (−4.20, 4.57) | 1.02 (0.83, 1.26) |
TTN | 291 | 10.73 | 51 | 11.97 | 0.84 (−2.48, 4.15) | 1.07 (0.79, 1.45) |
Neonatal sepsis | 318 | 11.73 | 48 | 11.27 | 0.85 (−2.22, 3.93) | 1.11 (0.81, 1.51) |
Pneumonia | 121 | 4.46 | 9 | 2.11 | −0.95 (−2.76, 0.86) | 0.60 (0.30, 1.19) |
RDS | 46 | 1.70 | 5 | 1.17 | −0.26 (−1.59, 1.07) | 0.84 (0.33, 2.14) |
Convulsions in newborn | 40 | 1.48 | 5 | 1.17 | −0.12 (−1.49, 1.24) | 0.98 (0.38, 2.50) |
TTN = transient tachypnea of the newborn; RDS = respiratory distress syndrome.
ICD-9 code 770.6.
ICD-9 codes 771.8, 771.81, 995.92, & 771.89.
ICD-9 codes 770.0 & 480.0–486.
ICD-9 codes 769, 770.84, & 770.87.
ICD-9 code 779.